REDWOOD CITY, Calif.--(BUSINESS WIRE)--Pulmonx Corporation, a leader in therapeutic pulmonary device technologies, announced today that its Zephyr® Valve is now covered by Priority Health® under its ...

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Pulmonx Corporation, a leader in therapeutic pulmonary device technologies, announced today that UnitedHealthcare®, the largest commercial insurer in the United ...

REDWOOD CITY, California, December 10, 2018 - Pulmonx, a leader in interventional pulmonary device technology announced today that the National Institute for Health and Care Excellence (NICE) in the ...

The approval was based on results from a multicenter study (LIBERATE) of 190 patients with severe emphysema. The Food and Drug Administration (FDA) has approved the Zephyr Endobronchial Valve (Pulmonx ...

Pulmonx, a leader in interventional pulmonary device technology announced today that the National Institute for Health and Care Excellence (NICE) in the UK has expanded its guidance on the diagnosis ...

Pulmonologists at Backus Hospital are now offering a procedure for patients with severe Chronic Obstructive Pulmonary Disease (COPD) that can greatly improve their breathing and their quality of life.

Two New Programs Aim to Improve Awareness and Support for Patients with Severe COPD/Emphysema REDWOOD CITY, Calif.--(BUSINESS WIRE)-- Pulmonx Corporation (LUNG) (Nasdaq: LUNG) (“Pulmonx”), a global ...

In a breakthrough for patients suffering from severe COPD or Emphysema, Metro Health – University of Michigan Health has become one of the first Michigan health systems to offer a new minimally ...

>> HOW ARE YOU FEELING, HOW’S YOUR BREATHING? >> GOOD. EMILY: THAT’S A NEW EXPERIENCE FOR RICHARD WELLS. FOR 15 YEARS, HE HAS STRUGGLED TO BREATHE. >> I JUST COULDN’T DO ANYTHING. COULDN’T DO ANYTHING ...

Pulmonx ® Corp. announced today that the U.S. Food and Drug Administration (FDA) has approved the Zephyr ® Endobronchial Valve System for treating severe emphysema patients. The Zephyr Valve is the ...